Tongue-Strengthening Exercises in Healthy Older Adults: Effect of Exercise Frequency - A Randomized Trial.

Detraining Dysphagia Tongue-strengthening exercises Training frequency

Journal

Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP)
ISSN: 1421-9972
Titre abrégé: Folia Phoniatr Logop
Pays: Switzerland
ID NLM: 9422792

Informations de publication

Date de publication:
2021
Historique:
received: 17 07 2019
accepted: 01 12 2019
pubmed: 6 2 2020
medline: 15 12 2021
entrez: 6 2 2020
Statut: ppublish

Résumé

Positive effects from tongue-strengthening exercises (TSE) are widely described, but dose-dependent studies concerning exercise frequency have not yet been reported. This study aimed to determine the training and detraining effects of TSE with exercise frequencies of respectively 3 and 5 times per week on maximum isometric anterior and posterior tongue pressures (MIPA and MIPP) and on anterior and posterior tongue strength during an effortful saliva swallow (PswalA and PswalP). Twenty healthy adults were randomly assigned to two exercise groups, training 3 (EX3, n = 10) or 5 (EX5, n = 10) times per week with the Iowa Oral Performance Instrument. MIPA, MIPP, PswalA, and PswalP were measured at baseline, after 4 and 8 weeks of training and 4 and 8 weeks after the last training session to document detraining effects. Descriptive statistics, linear mixed model effects, and post hoc analyses were calculated. Significant increases in MIPA, MIPP, PswalA, and PswalP were measured for training both 3 and 5 times per week. No significant differences on any parameter were found between EX3 and EX5 groups. No significant detraining effects were found after 4 or 8 weeks in any treatment arm either for MIPs or for effortful swallow pressures. This randomized study demonstrated a positive effect of TSE on MIP and Pswal in healthy older adults, without detraining effects. No superiority of exercise frequency was identified based on significance testing, although some trends are discussed.

Identifiants

pubmed: 32023617
pii: 000505153
doi: 10.1159/000505153
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-116

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Leen Van den Steen (L)

Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium, Leen.vandensteen@gmail.com.
Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium, Leen.vandensteen@gmail.com.

Marc De Bodt (M)

Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Department of Speech, Language and Hearing Sciences, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.

Cindy Guns (C)

Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.

Rik Elen (R)

Department of Speech, Language and Audiology, Thomas More University College of Applied Sciences, Antwerp, Belgium.

Jan Vanderwegen (J)

Department of Speech, Language and Audiology, Thomas More University College of Applied Sciences, Antwerp, Belgium.
Department of Otolaryngology and Head and Neck Surgery, CHU Saint-Pierre, Brussels, Belgium.

Gwen Van Nuffelen (G)

Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Department of Speech, Language and Hearing Sciences, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH